XAUS:LSE:LSE-Xtrackers S&P ASX 200 UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 3491.5

Change

-10.00 (-0.29)%

Market Cap

N/A

Volume

672.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.75 (-2.49%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.84 (-0.70%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.08 (-0.45%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.38%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.35%)

USD 266.08B
0QZO:LSE 0QZO

-1.05 (-1.09%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-4.82 (-2.77%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

-0.12 (-0.38%)

USD 200.79B
0R24:LSE Intel Corp.

-0.35 (-1.47%)

USD 196.14B

ETFs Containing XAUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.19% 38% F 45% F
Dividend Return 0.03% 30% F 41% F
Total Return 4.23% 36% F 45% F
Trailing 12 Months  
Capital Gain 15.86% 54% F 57% F
Dividend Return 0.04% 29% F 36% F
Total Return 15.90% 52% F 56% F
Trailing 5 Years  
Capital Gain 13.60% 37% F 49% F
Dividend Return 0.10% 21% F 17% F
Total Return 13.70% 34% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 4.62% N/A N/A 54% F
Dividend Return 4.64% N/A N/A 54% F
Total Return 0.02% N/A N/A 20% F
Risk Return Profile  
Volatility (Standard Deviation) 12.35% N/A N/A 72% C
Risk Adjusted Return 37.55% N/A N/A 65% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike